CINCINNATI, Nov. 11, 2010 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming Lazard Capital Markets 7th Annual Healthcare Conference on Nov. 16, 2010 at the St. Regis New York in New York City.
Kendle’s formal presentation will be given at 2:10 p.m. Eastern Time by Stephen Cutler, PhD, Senior Vice President and Chief Operating Officer and Keith Cheesman, Senior Vice President and Chief Financial Officer.
The presentation will be webcast and may be accessed at www.kendle.com in the “Investors Events & Presentations” section or at http://www.wsw.com/webcast/lz8/kndl/
Slides will be available by 11 a.m. on the day of the presentation at www.kendle.com in the “Investors Events & Presentations” section. The webcast will be archived for 90 days following the live presentation.
About Kendle
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of clinical development services for the world’s biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide. As one of the world’s largest global providers of clinical development services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers’ clinical development challenges.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company’s website at www.kendle.com.
SOURCE Kendle International Inc.
